Vimarsana
Biggest News Aggregation in the World

Becky Malone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Becky Malone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Becky Malone Today - Breaking & Trending Today

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT - Vimarsana News

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT

UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting Diverse and...

UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting - Vimarsana News

UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting

Study presents new persistence analysis of FINTEPLA, evaluating the efficacy and tolerability of FINTEPLA over a span of 12 months1 Real-world data looks into the need for resources to support caregivers – both parents and siblings – of people living with developmental and epileptic encephalopathies such as Dravet and Lennox-Gastaut syndromes in the transition from […]

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting - Vimarsana News

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

UCB will present 29 abstracts, including 4 late breakers, at American Epilepsy Society Annual Meeting 2023 highlighting clinical, health economic and...

NAYZILAM® (midazolam) Results Published in 'Epilepsy & Behavior' Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters - Vimarsana News

NAYZILAM® (midazolam) Results Published in 'Epilepsy & Behavior' Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters

Median time to return to full baseline function occurred within 90 minutes following outpatient treatment with NAYZILAM® (midazolam) nasal spray, with a...

UCB presents late-breaking posters at Child Neurology Society Meeting - Vimarsana News

UCB presents late-breaking posters at Child Neurology Society Meeting

/PRNewswire/ -- The Child Neurology Society Meeting, a prominent event in the field of pediatric neurology, is set to showcase cutting-edge research and...